Johnson & Johnson's Income Statement Analysis: Revenue to Profit Breakdown
Johnson & Johnson's Income Statement Analysis: Revenue to Profit Breakdown
|
|
Chart |
FY21
Dec 31, 2021
|
FY22
Dec 31, 2022
|
FY23
Dec 31, 2023
|
FY24
Dec 29, 2024
|
FY25
Dec 31, 2025
|
TTM
Trailing 12M
|
|---|---|---|---|---|---|---|---|
|
Revenue
Total sales generated. |
|
$78.74 B | $79.99 B | $85.16 B | $88.82 B | $94.19 B | $96.36 B |
|
Cost of Revenue Direct cost of goods/services. |
|
$23.40 B | $24.60 B | $26.55 B | $27.47 B | $25.64 B | $29.76 B |
Gross Profit Revenue minus cost of revenue. |
|
$55.34 B | $55.39 B | $58.61 B | $61.35 B | $68.56 B | $66.60 B |
|
Operating Expense
Costs to run business. |
|
$34.40 B | $34.38 B | $35.20 B | $39.20 B | $42.96 B | $40.71 B |
Research and Development Investment in innovation. |
|
$14.28 B | $14.14 B | $15.09 B | $17.23 B | $14.67 B | $14.97 B |
|
Sales, General and Administrative
Selling and admin costs. |
|
$20.12 B | $20.25 B | $20.11 B | $21.97 B | $23.68 B | $24.50 B |
General and Administrative Corporate overhead costs. |
|
$20.12 B | $20.25 B | $20.11 B | $21.97 B | $23.68 B | $11.71 B |
Sales and Marketing Customer acquisition costs. |
|
- | - | - | - | - | - |
Other Expenses Other operating costs. |
|
- | - | - | - | $4.62 B | $1.25 B |
Operating Income Profit from operations. |
|
$20.94 B | $21.01 B | $23.41 B | $22.15 B | $25.60 B | $25.89 B |
|
Net Interest Income
Interest income minus expense. |
|
-$130.00 M | $214.00 M | $489.00 M | $577.00 M | $85.00 M | -$86.00 M |
Interest Income Income from investments. |
|
$53.00 M | $490.00 M | $1.26 B | $1.33 B | $85.00 M | $724.00 M |
Interest Expense Cost of borrowing. |
|
$183.00 M | $276.00 M | $772.00 M | $755.00 M | - | $810.00 M |
Non-Operating Income (ex-Int) Income outside core operations. |
|
$1.58 B | $1.38 B | $7.58 B | $4.71 B | -$6.99 B | $7.00 M |
Total Other Income (Net) Net non-operating items. |
|
-$1.77 B | -$1.65 B | -$8.35 B | -$5.46 B | $6.99 B | -$952.00 M |
Income Before Tax Profit before taxes. |
|
$19.18 B | $19.36 B | $15.06 B | $16.69 B | $32.58 B | $24.94 B |
Income Tax Expense Taxes on income. |
|
$1.38 B | $2.99 B | $1.74 B | $2.62 B | $5.78 B | $3.90 B |
|
Net Income
Final profit. |
|
$20.88 B | $17.94 B | $35.15 B | $14.07 B | $26.80 B | $21.04 B |
Net Income From Continuing Operations Profit from core business. |
|
$17.80 B | $16.37 B | $13.33 B | $14.07 B | $26.80 B | $21.04 B |
Net Income From Discontinued Operations Profit/loss from sold units. |
|
$3.08 B | $1.57 B | $21.83 B | - | - | - |
Other Adjustments to Net Income Additional accounting adjustments. |
|
- | - | - | - | - | - |
Net Income Deductions Reductions from net income. |
|
- | - | - | - | - | - |
|
Earnings Per Share
Company profit allocated to each outstanding share. |
|||||||
EPS Earnings per share. Formula: Net Income ÷ Shares |
|
$7.93 | $6.83 | $13.88 | $5.84 | - | $8.67 |
Diluted EPS EPS including dilution. Formula: Net Income ÷ Diluted Shares |
|
$7.81 | $6.73 | $13.72 | $5.79 | $11.03 | $8.65 |
|
Shares for EPS
Number of shares used to calculate EPS. |
|||||||
Weighted Average Shares Outst. Avg shares used for EPS. |
|
2.63 B | 2.61 B | 2.53 B | 2.41 B | 2.43 B | 2.45 B |
Diluted Average Shares Outst. Shares including dilution. |
|
2.67 B | 2.66 B | 2.56 B | 2.43 B | 2.43 B | 2.45 B |
| Supplemental Items | |||||||
EBIT Earnings before interest and tax. |
|
$19.36 B | $19.64 B | $15.83 B | $17.44 B | $32.58 B | $25.89 B |
EBITDA Earnings before interest, tax, D&A. |
|
$26.75 B | $26.61 B | $23.32 B | $24.78 B | $32.58 B | $31.62 B |
Depreciation and Amortization Non-cash expense for assets. |
|
$7.39 B | $6.97 B | $7.49 B | $7.34 B | - | $5.73 B |
| Company Report |
Johnson & Johnson's Assets vs Liabilities & Equity
Johnson & Johnson's Assets vs Liabilities & Equity
| Loading balance sheet when needed... |
| Loading cash flow statement when needed... |
| Loading profitability metrics when needed... |




